Next, we took advantage of a TMA comprising prostate cancer specimens from 88 patients and evaluated PKCα staining by IHC using an anti-PKCα antibody previously validated in PKCα wild-type versus knockout mice (25), followed by a quantitative analysis reported as H score. Here, PRKCA is linked to prostate cancer.